About Translocon-associated protein subunit alpha
Translocon-associated protein subunit alpha (SSR1) is a protein
from Homo sapiens identified by UniProt accession
P43307, 286 residues long.
MolForge cross-references it against 0 known binders and
146 disease associations.
Target properties
| Protein name | Translocon-associated protein subunit alpha |
| UniProt accession | P43307 |
| Gene | SSR1 |
| Organism | Homo sapiens |
| Length | 286 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (146)
Diseases linked to this target (Open Targets).
- type 2 diabetes mellitus · score 0.40
- serum alanine aminotransferase measurement · score 0.34
- neurodegenerative disease · score 0.33
- heel bone mineral density · score 0.32
- leukocyte count · score 0.30
- Immature Reticulocyte Fraction Measurement · score 0.27
- sitting height measurement · score 0.20
- reticulocyte measurement · score 0.19
- high density lipoprotein cholesterol measurement · score 0.18
- sex hormone-binding globulin measurement · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P43307-F1 | alphafold | PREDICTED | 76.10 | — |
Amino-acid sequence (286 residues)
MRLLPRLLLL LLLVFPATVL FRGGPRGLLA VAQDLTEDEE TVEDSIIEDE DDEAEVEEDE PTDLVEDKEE EDVSGEPEAS PSADTTILFV KGEDFPANNI VKFLVGFTNK GTEDFIVESL DASFRYPQDY QFYIQNFTAL PLNTVVPPQR QATFEYSFIP AEPMGGRPFG LVINLNYKDL NGNVFQDAVF NQTVTVIERE DGLDGETIFM YMFLAGLGLL VIVGLHQLLE SRKRKRPIQK VEMGTSSQND VDMSWIPQET LNQINKASPR RLPRKRAQKR SVGSDE
Explore Translocon-associated protein subunit alpha with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets